JASON POSTULA: Open Payments
NPI 1710915905 · SOUTH LYON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 46 payments from 10 companies in 2025. Trend: 2023 $1,208 · 2024 $523 · 2025 $942
Food & beverage: $942
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $302 |
| Lilly USA, LLC | 8 | $137 |
| Exact Sciences Corporation | 6 | $134 |
| Novo Nordisk Inc | 5 | $91 |
| Axsome Therapeutics, Inc. | 4 | $80 |
| Aimmune Therapeutics, Inc. | 4 | $70 |
| PFIZER INC. | 3 | $52 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| ABBVIE INC. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: AIRSUPRA, MOUNJARO, Cologuard Collection Kit, Auvelity, BREZTRI, ZENPEP, Ozempic, SHINGRIX.
Industry payments across MI — which companies pay providers there.
